GHRP-2 (Pralmorelin) is a potent second-generation synthetic hexapeptide ghrelin mimetic acting on pituitary and hypothalamic GHS-R1a receptors, widely benchmarked in somatotropic secretion assays.
Scientific Profile & Research Key Points: GHRP-2
GHRP-2 (Pralmorelin) is a potent second-generation synthetic hexapeptide ghrelin mimetic acting on pituitary and hypothalamic GHS-R1a receptors, widely benchmarked in somatotropic secretion assays.
Active Batch Release Specifications (Lot SL-2026-125)
Analytical release verification for current GHRP-2 (5 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-125 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)
Temperature & Stability
Store lyophilized at -20°C shielded from light; refrigerate solution at 2°C–8°C for up to 28 days.
GHRP-2 — Technical Questions & Answers
What is the molar concentration when reconstituting GHRP-2 (5 mg) in 2.0 mL?
Reconstituting the full 5 mg vial of GHRP-2 (MW 817.97 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 3.06 mM (3,056 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does GHRP-2's counterion stoichiometry affect assay mass calculations?
GHRP-2 (CAS 158861-67-7, formula C45H55N9O6) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify GHRP-2 Lot SL-2026-125 and what pathway does it target?
Lot SL-2026-125 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 817.97 g/mol. In preclinical literature, GHRP-2 targets Growth Hormone Secretagogue Receptor 1a (GHS-R1a) (Bowers C.Y., J Clin Endocrinol Metab (1998) — Growth hormone-releasing peptide GHRP-2 receptor pharmacology).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
CJC-1295, Ipamorelin, and Sermorelin: GHRH Analogues vs Ghrelin Receptor Agonists
A deep dive into somatotropic axis stimulation. Comparing GHRH receptor binding, DAC modification kinetics, ghrelin/GHS-R1a agonism, and pulsatile growth hormone secretion.
Gonadorelin, HCG, HMG and Kisspeptin: Mapping the Hypothalamic-Pituitary-Gonadal Axis
A comparative map of the HPG axis: GnRH receptor agonism (Gonadorelin), LH receptor mimetics (HCG), combined FSH/LH activity (HMG), and upstream GPR54 activation (Kisspeptin-10).
Human Growth Hormone (191aa): Somatropin Structure, Isoforms, and SEC-HPLC Analysis
A deep analysis of authentic 191-amino acid Somatropin vs 192-amino acid Somatrem. Size-exclusion chromatography (SEC), deamidation artifacts, and mass confirmation.
Related GH Secretagogues & Growth Factors Compounds
View category →